TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 80 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2014. The put-call ratio across all filers is 5.00 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $111 | +6.7% | 2,934 | +6.8% | 0.00% | – |
| Q2 2023 | $104 | +55.2% | 2,747 | -0.7% | 0.00% | – |
| Q1 2023 | $67 | -17.3% | 2,766 | -1.4% | 0.00% | – |
| Q4 2022 | $81 | -99.9% | 2,805 | -0.4% | 0.00% | – |
| Q3 2022 | $84,000 | -16.8% | 2,815 | +0.3% | 0.00% | – |
| Q2 2022 | $101,000 | -20.5% | 2,806 | -4.5% | 0.00% | – |
| Q1 2022 | $127,000 | -13.0% | 2,938 | +0.5% | 0.00% | – |
| Q4 2021 | $146,000 | -26.6% | 2,922 | -6.7% | 0.00% | -100.0% |
| Q3 2021 | $199,000 | -17.8% | 3,133 | -6.8% | 0.00% | 0.0% |
| Q2 2021 | $242,000 | -1.6% | 3,360 | +0.8% | 0.00% | 0.0% |
| Q1 2021 | $246,000 | -58.9% | 3,332 | -22.0% | 0.00% | -66.7% |
| Q2 2014 | $599,000 | +25.8% | 4,270 | -0.4% | 0.00% | +50.0% |
| Q1 2014 | $476,000 | +41.7% | 4,287 | +26.2% | 0.00% | 0.0% |
| Q4 2013 | $336,000 | – | 3,397 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 78,905 | $8,306,000 | 7.65% |
| FORT, L.P. | 157,584 | $16,589,000 | 4.68% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 808,200 | $85,079,000 | 4.39% |
| Strategic Global Advisors, LLC | 81,432 | $8,572,000 | 3.18% |
| Prince Street Capital Management LLC | 48,700 | $5,127,000 | 1.62% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,309,000 | 1.45% |
| Freestone Capital Holdings, LLC | 84,900 | $8,937,000 | 0.77% |
| RPG Investment Advisory, LLC | 17,227 | $1,813,000 | 0.61% |
| CLINTON GROUP INC | 46,370 | $4,881,000 | 0.28% |
| USA FINANCIAL FORMULAS | 10,786 | $1,135,000 | 0.28% |